225 related articles for article (PubMed ID: 9333569)
1. Efficacy trial of acellular pertussis vaccines; trial I.
Olin P
Dev Biol Stand; 1997; 89():52-4. PubMed ID: 9333569
[No Abstract] [Full Text] [Related]
2. A comparative efficacy trial in Germany in which infants received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) vaccine or DT vaccine.
Stehr K; Cherry JD
Dev Biol Stand; 1997; 89():58-62. PubMed ID: 9333571
[No Abstract] [Full Text] [Related]
3. The Gothenburg pertussis vaccine study.
Trollfors B; Taranger J
Dev Biol Stand; 1997; 89():49-51. PubMed ID: 9333568
[No Abstract] [Full Text] [Related]
4. Italian trial on acellular pertussis vaccines.
Greco D
Dev Biol Stand; 1997; 89():55-7. PubMed ID: 9333570
[No Abstract] [Full Text] [Related]
5. Sénégal pertussis trial.
Simondon F
Dev Biol Stand; 1997; 89():63-6. PubMed ID: 9333572
[No Abstract] [Full Text] [Related]
6. Safety evaluation of one whole-cell and three acellular pertussis vaccines in Stockholm trial II.
Heijbel H; Rasmussen F; Olin P
Dev Biol Stand; 1997; 89():99-100. PubMed ID: 9272337
[No Abstract] [Full Text] [Related]
7. Implications of different study designs for the evaluation of acellular pertussis vaccines.
Fine PE
Dev Biol Stand; 1997; 89():123-33. PubMed ID: 9272342
[TBL] [Abstract][Full Text] [Related]
8. Severe adverse events in the Italian and Stockholm I pertussis vaccine clinical trials.
Ciofi degli Atti ML; Olin P
Dev Biol Stand; 1997; 89():77-81. PubMed ID: 9272334
[TBL] [Abstract][Full Text] [Related]
9. Hypotonic hyporesponsive episodes in eight pertussis vaccine studies.
Heijbel H; Ciofi degli Atti M; Harzer E; Liese J; Preziosi MP; Rasmussen F; Schmitt HJ; Storsaeter J; Taranger J; Uberall M; Tozzi AE
Dev Biol Stand; 1997; 89():101-3. PubMed ID: 9272338
[No Abstract] [Full Text] [Related]
10. A placebo-controlled trial of a pertussis-toxoid vaccine.
Trollfors B; Taranger J; Lagergård T; Lind L; Sundh V; Zackrisson G; Lowe CU; Blackwelder W; Robbins JB
N Engl J Med; 1995 Oct; 333(16):1045-50. PubMed ID: 7675047
[TBL] [Abstract][Full Text] [Related]
11. Case-control study to evaluate the efficacy of the BIKEN acellular pertussis vaccine combined with diphtheria and tetanus toxoids (DTaP) in infants.
Beloradsky BH
Dev Biol Stand; 1997; 89():70-3. PubMed ID: 9333574
[No Abstract] [Full Text] [Related]
12. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
13. Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group.
Schmitt-Grohé S; Stehr K; Cherry JD; Heininger U; Uberall MA; Laussucq S; Eckhardt T
Dev Biol Stand; 1997; 89():113-8. PubMed ID: 9272341
[TBL] [Abstract][Full Text] [Related]
14. Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group.
Uberall MA; Stehr K; Cherry JD; Heininger U; Schmitt-Grohé S; Laussucq S; Eckhardt T
Dev Biol Stand; 1997; 89():83-9. PubMed ID: 9272335
[TBL] [Abstract][Full Text] [Related]
15. Adverse reactions of a pertussis toxoid vaccine in a double-blind placebo-controlled trial.
Taranger J; Trollfors B; Knutsson N
Dev Biol Stand; 1997; 89():109-12. PubMed ID: 9272340
[TBL] [Abstract][Full Text] [Related]
16. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C
Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussis.
Trollfors B; Taranger J; Lagergård T; Lind L; Sundh V; Zackrisson G; Bryla DA; Robbins JB
J Pediatr; 1997 Apr; 130(4):532-6. PubMed ID: 9108848
[TBL] [Abstract][Full Text] [Related]
18. Reduced immunogenicity of diphtheria and tetanus toxoids when combined with pertussis toxoid.
Trollfors B; Taranger J; Lagergård T; Sundh V
Pediatr Infect Dis J; 2005 Jan; 24(1):85-6. PubMed ID: 15665717
[TBL] [Abstract][Full Text] [Related]
19. Common side effects in the Italian and Stockholm I trials.
Tozzi AE; Olin P
Dev Biol Stand; 1997; 89():105-8. PubMed ID: 9272339
[TBL] [Abstract][Full Text] [Related]
20. Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection.
Heininger U; Stehr K; Christenson P; Cherry JD
Clin Infect Dis; 1999 Mar; 28(3):602-4. PubMed ID: 10194085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
